from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3486/-

LFCtreatmentdescriptionclass of inhibitor

0.212

Amikacinug/mL Amikacintranslation

0.618

Cap5-10ug/mL Capreomycintranslation

0.557

Rox10-50 ug/mL Roxithromycintranslation

-0.250

SM2-5 ug/mL Streptomycintranslation

1.028

Tet5-10 ug/mL Tetracyclinetranslation

0.065

Rif0.2-5ug/mL Rifampicintranscription

-1.244

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.037

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.927

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.473

CPZ10-50 ug/mL Chlorpromazinerespiration

3.377

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.240

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.016

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.196

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.734

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.094

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.448

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.359

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.286

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.542

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.891

KCN5-20 ug/mL Potassium cyaniderespiration

-0.193

NaN30.2-2 mM Sodium aziderespiration

-1.352

Nigericin50 uM Nigericinrespiration

-0.024

TRC10-150 ug/mL Triclosanrespiration

1.152

TRZ10-25 ug/mL Thioridazinerespiration

1.453

Valinomycin0.5-10 uM Valinomycinrespiration

-0.770

ZnSO42 mM ZnSO4respiration

-0.347

menadione6-10 ug/mL Menadionerespiration

0.733

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.635

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.222

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.386

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.180

NRP_1Non-replicating persistence stage 1dosRassociated

-0.807

Amp0.2mg/mL AmpicillincellWall

-0.300

Cephalexin20-100 ug/mL CephalexincellWall

-0.112

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.269

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.290

EMB10-20 ug/mL EthambutolcellWall

-0.598

Eta12-40 ug/mL EthionamidecellWall

-0.827

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.184

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.480

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.918

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.700

BZA0.12 mg/mL BenzamidearomaticAmides

-0.164

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.127

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.873

H2O24 mM hydrogen peroxideDNAdamaging

-0.551

Levo10 ug/mL LevofloxacinDNAdamaging

0.009

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.311

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.384

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.071

UVUV-irradiationDNAdamaging

1.224

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.241

Antimycin12.5-50 ug/mL Antimycin A?

-0.368

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.882

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.526

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.646

PA8240.2-2 ug/mL PA-824?

1.355

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.099

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.189

Verapamil50 uM Verapamil?

-0.541

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.990

methoxatin10-20 ug/mL Methoxatin?